AAPL332.56+5.99 (+1.83%) ▲|ABBV257.01+2.01 (+0.79%) ▲|ABT102.12-1.24 (-1.20%) ▼|ACN183.71+5.80 (+3.26%) ▲|ADBE253.64+4.81 (+1.93%) ▲|AMAT457.52+3.51 (+0.77%) ▲|AMD516.23+12.63 (+2.51%) ▲|AMGN378.14-4.33 (-1.13%) ▼|AMT178.05+5.07 (+2.93%) ▲|AMZN257.23+5.34 (+2.12%) ▲|AVGO362.85+2.02 (+0.56%) ▲|AXP324.25+3.54 (+1.10%) ▲|BA210.62+5.82 (+2.84%) ▲|BAC62.73+0.17 (+0.26%) ▲|BKNG174.01+0.10 (+0.06%) ▲|BLK1,081.85+19.45 (+1.83%) ▲|BMY63.47-0.28 (-0.44%) ▼|BNY162.85+0.26 (+0.16%) ▲|BRK-B509.53+2.53 (+0.50%) ▲|C138.96+0.46 (+0.33%) ▲|CAT819.79+14.79 (+1.84%) ▲|CL86.45-1.45 (-1.65%) ▼|CMCSA25.16-0.01 (-0.04%) ▼|COF208.31+1.20 (+0.58%) ▲|COP136.75-0.30 (-0.22%) ▼|COST905.17+2.79 (+0.31%) ▲|CRM248.34+5.34 (+2.20%) ▲|CSCO111.64+4.20 (+3.91%) ▲|CVS94.47-0.82 (-0.86%) ▼|CVX213.94+1.18 (+0.55%) ▲|DE676.98-0.96 (-0.14%) ▼|DHR200.43-0.11 (-0.05%) ▼|DIS106.50+0.68 (+0.64%) ▲|DUK119.41+0.04 (+0.03%) ▲|EMR152.04+3.67 (+2.47%) ▲|FDX312.41+0.61 (+0.20%) ▲|GD356.43+2.18 (+0.62%) ▲|GE324.16+0.01 (+0.00%) ▲|GEV956.03+32.12 (+3.48%) ▲|GILD143.94-0.87 (-0.60%) ▼|GM85.70-0.42 (-0.49%) ▼|GOOG336.04+5.65 (+1.71%) ▲|GOOGL339.05+6.45 (+1.94%) ▲|GS1,028.66+8.89 (+0.87%) ▲|HD309.02+3.33 (+1.09%) ▲|HON201.95-0.23 (-0.11%) ▼|IBM242.75+8.73 (+3.73%) ▲|INTC103.05+2.73 (+2.72%) ▲|INTU322.30+9.53 (+3.05%) ▲|ISRG371.30+10.84 (+3.01%) ▲|JNJ265.82-0.54 (-0.20%) ▼|JPM356.26+2.70 (+0.76%) ▲|KO88.47+0.64 (+0.73%) ▲|LIN466.99+5.37 (+1.16%) ▲|LLY1,118.14-4.86 (-0.43%) ▼|LMT524.52-5.60 (-1.06%) ▼|LOW196.94+0.35 (+0.18%) ▲|LRCX299.05+1.04 (+0.35%) ▲|MA572.42+7.05 (+1.25%) ▲|MCD252.83-0.22 (-0.09%) ▼|MDLZ62.38-0.09 (-0.14%) ▼|MDT90.78-0.84 (-0.91%) ▼|META649.36+4.98 (+0.77%) ▲|MMM164.85+1.99 (+1.22%) ▲|MO69.00+0.21 (+0.30%) ▲|MRK144.46-0.26 (-0.18%) ▼|MS214.50+1.84 (+0.87%) ▲|MSFT496.93+4.49 (+0.91%) ▲|MU975.69-1.72 (-0.18%) ▼|NEE82.39-0.06 (-0.07%) ▼|NFLX77.51+1.50 (+1.97%) ▲|NKE36.89+0.27 (+0.72%) ▲|NOW132.81+1.64 (+1.25%) ▲|NVDA218.51+0.15 (+0.07%) ▲|ORCL151.13-1.81 (-1.18%) ▼|PEP136.28-0.37 (-0.27%) ▼|PFE27.62-0.03 (-0.12%) ▼|PG145.07+2.10 (+1.47%) ▲|PLTR167.54+1.68 (+1.02%) ▲|PM192.92+3.15 (+1.66%) ▲|QCOM182.35+5.47 (+3.09%) ▲|RTX197.48-0.64 (-0.32%) ▼|SBUX98.82-0.41 (-0.41%) ▼|SCHW107.02-0.31 (-0.29%) ▼|SO87.20-0.55 (-0.63%) ▼|SPG205.02+0.35 (+0.17%) ▲|T26.05+0.50 (+1.96%) ▲|TMO613.07+9.89 (+1.64%) ▲|TMUS183.34+6.18 (+3.49%) ▲|TSLA365.06+1.50 (+0.41%) ▲|TXN268.45+9.63 (+3.72%) ▲|UBER71.80-0.76 (-1.05%) ▼|UNH378.39-9.89 (-2.55%) ▼|UNP284.76-1.02 (-0.36%) ▼|UPS99.95-0.03 (-0.03%) ▼|USB62.84+0.43 (+0.68%) ▲|V371.10+3.89 (+1.06%) ▲|VZ50.52+0.55 (+1.09%) ▲|WFC90.12+0.67 (+0.74%) ▲|WMT107.14+1.41 (+1.33%) ▲|XOM165.30+0.07 (+0.04%) ▲|AAPL332.56+5.99 (+1.83%) ▲|ABBV257.01+2.01 (+0.79%) ▲|ABT102.12-1.24 (-1.20%) ▼|ACN183.71+5.80 (+3.26%) ▲|ADBE253.64+4.81 (+1.93%) ▲|AMAT457.52+3.51 (+0.77%) ▲|AMD516.23+12.63 (+2.51%) ▲|AMGN378.14-4.33 (-1.13%) ▼|AMT178.05+5.07 (+2.93%) ▲|AMZN257.23+5.34 (+2.12%) ▲|AVGO362.85+2.02 (+0.56%) ▲|AXP324.25+3.54 (+1.10%) ▲|BA210.62+5.82 (+2.84%) ▲|BAC62.73+0.17 (+0.26%) ▲|BKNG174.01+0.10 (+0.06%) ▲|BLK1,081.85+19.45 (+1.83%) ▲|BMY63.47-0.28 (-0.44%) ▼|BNY162.85+0.26 (+0.16%) ▲|BRK-B509.53+2.53 (+0.50%) ▲|C138.96+0.46 (+0.33%) ▲|CAT819.79+14.79 (+1.84%) ▲|CL86.45-1.45 (-1.65%) ▼|CMCSA25.16-0.01 (-0.04%) ▼|COF208.31+1.20 (+0.58%) ▲|COP136.75-0.30 (-0.22%) ▼|COST905.17+2.79 (+0.31%) ▲|CRM248.34+5.34 (+2.20%) ▲|CSCO111.64+4.20 (+3.91%) ▲|CVS94.47-0.82 (-0.86%) ▼|CVX213.94+1.18 (+0.55%) ▲|DE676.98-0.96 (-0.14%) ▼|DHR200.43-0.11 (-0.05%) ▼|DIS106.50+0.68 (+0.64%) ▲|DUK119.41+0.04 (+0.03%) ▲|EMR152.04+3.67 (+2.47%) ▲|FDX312.41+0.61 (+0.20%) ▲|GD356.43+2.18 (+0.62%) ▲|GE324.16+0.01 (+0.00%) ▲|GEV956.03+32.12 (+3.48%) ▲|GILD143.94-0.87 (-0.60%) ▼|GM85.70-0.42 (-0.49%) ▼|GOOG336.04+5.65 (+1.71%) ▲|GOOGL339.05+6.45 (+1.94%) ▲|GS1,028.66+8.89 (+0.87%) ▲|HD309.02+3.33 (+1.09%) ▲|HON201.95-0.23 (-0.11%) ▼|IBM242.75+8.73 (+3.73%) ▲|INTC103.05+2.73 (+2.72%) ▲|INTU322.30+9.53 (+3.05%) ▲|ISRG371.30+10.84 (+3.01%) ▲|JNJ265.82-0.54 (-0.20%) ▼|JPM356.26+2.70 (+0.76%) ▲|KO88.47+0.64 (+0.73%) ▲|LIN466.99+5.37 (+1.16%) ▲|LLY1,118.14-4.86 (-0.43%) ▼|LMT524.52-5.60 (-1.06%) ▼|LOW196.94+0.35 (+0.18%) ▲|LRCX299.05+1.04 (+0.35%) ▲|MA572.42+7.05 (+1.25%) ▲|MCD252.83-0.22 (-0.09%) ▼|MDLZ62.38-0.09 (-0.14%) ▼|MDT90.78-0.84 (-0.91%) ▼|META649.36+4.98 (+0.77%) ▲|MMM164.85+1.99 (+1.22%) ▲|MO69.00+0.21 (+0.30%) ▲|MRK144.46-0.26 (-0.18%) ▼|MS214.50+1.84 (+0.87%) ▲|MSFT496.93+4.49 (+0.91%) ▲|MU975.69-1.72 (-0.18%) ▼|NEE82.39-0.06 (-0.07%) ▼|NFLX77.51+1.50 (+1.97%) ▲|NKE36.89+0.27 (+0.72%) ▲|NOW132.81+1.64 (+1.25%) ▲|NVDA218.51+0.15 (+0.07%) ▲|ORCL151.13-1.81 (-1.18%) ▼|PEP136.28-0.37 (-0.27%) ▼|PFE27.62-0.03 (-0.12%) ▼|PG145.07+2.10 (+1.47%) ▲|PLTR167.54+1.68 (+1.02%) ▲|PM192.92+3.15 (+1.66%) ▲|QCOM182.35+5.47 (+3.09%) ▲|RTX197.48-0.64 (-0.32%) ▼|SBUX98.82-0.41 (-0.41%) ▼|SCHW107.02-0.31 (-0.29%) ▼|SO87.20-0.55 (-0.63%) ▼|SPG205.02+0.35 (+0.17%) ▲|T26.05+0.50 (+1.96%) ▲|TMO613.07+9.89 (+1.64%) ▲|TMUS183.34+6.18 (+3.49%) ▲|TSLA365.06+1.50 (+0.41%) ▲|TXN268.45+9.63 (+3.72%) ▲|UBER71.80-0.76 (-1.05%) ▼|UNH378.39-9.89 (-2.55%) ▼|UNP284.76-1.02 (-0.36%) ▼|UPS99.95-0.03 (-0.03%) ▼|USB62.84+0.43 (+0.68%) ▲|V371.10+3.89 (+1.06%) ▲|VZ50.52+0.55 (+1.09%) ▲|WFC90.12+0.67 (+0.74%) ▲|WMT107.14+1.41 (+1.33%) ▲|XOM165.30+0.07 (+0.04%) ▲|
26.7 C
New York
Friday, September 11, 2026

Tag: filings

newssourceFORcompanyinformationcontent1releasesmarket

Q2 Sales and H1 2025 Financial Results

 

Raytech Holding Limited Announces Fiscal Year 2025 Financial Results and the Filing of Its Annual Report on Form 20-F

Revenue Growth of 17.6% to HK$78.7 Million (US$10.1 million); Strong Cash Position of HK$84.9 Million (US$10.9 million) 
Revenue Growth of 17.6% to HK$78.7 Million (US$10.1 million); Strong Cash Position of HK$84.9 Million (US$10.9 million)

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025

Davis Commodities Evaluates Stablecoin Licensing and ESG Tokenization Frameworks Amid Growing Momentum in Regulated Digital Finance

Davis Commodities explores stablecoin licensing and ESG tokenization to align with evolving regulations and $10T tokenized asset growth.

Davis Commodities Reviews Bitcoin Reserve Model and Tokenized ESG Infrastructure Amid $16 Trillion Digital Asset Surge

Davis Commodities reviews Bitcoin reserves and tokenized ESG assets, targeting $16T RWA market with blockchain-driven capital strategies.

Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

COPENHAGEN, Denmark, July 25, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will be presenting two-year clinical efficacy data from its phase 2 trial with lead compound EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2025 to be held in Berlin, Germany, from October 17-21, 2025.

LOBO EV Technologies Ltd. Issues Statement Regarding Recent Market Activity

WUXI, China, July 25, 2025 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (Nasdaq: LOBO) (“LOBO” or the “Company”), a developer and manufacturer in electric mobility and intelligent systems, today issued a statement regarding recent trading activity in its common stock.

First Hawaiian, Inc. Reports Second Quarter 2025 Financial Results and Declares Dividend

HONOLULU, July 25, 2025 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ:FHB), (“First Hawaiian” or the “Company”) today reported financial results for its quarter ended June 30, 2025.

Fusion Fuel Announces New LPG Projects for Subsidiary Al Shola Gas

DUBLIN, July 25, 2025 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a provider of integrated energy solutions, today announced that, in July 2025, its majority-owned operating subsidiary, Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), confirmed a number of new projects for the installation and maintenance of liquefied petroleum gas (“LPG”) systems and the supply of bulk LPG across multiple large-scale residential and commercial developments in Dubai, United Arab Emirates.

First Citizens BancShares Reports Second Quarter 2025 Earnings, Announces Additional Share Repurchase Plan

RALEIGH, N.C., July 25, 2025 /PRNewswire/ -- First Citizens BancShares, Inc. ("BancShares") (Nasdaq: FCNCA) reported earnings for the second quarter of 2025.  ...

Lear Reports Second Quarter 2025 Results

SOUTHFIELD, Mich., July 25, 2025 /PRNewswire/ -- Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, today reported results for the second...

Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer’s disease

The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and...

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

NEW YORK and MAINZ, GERMANY, July 25, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The adaptation is based on the recommendation from the EMA’s Emergency Task Force (ETF) to update COVID-19 vaccines to target the LP.8.1 variant for the 2025-2026 season. The ETF stated that “targeting LP.8.1 will help maintain the effectiveness of the vaccines as SARS-CoV-2 continues to evolve.”2

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFilings

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers